OOIR: Observatory of International Research

Papers

(The median citation count of Personalized Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension	65
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients	29
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness	22
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population	17
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia	16
An evidence gap map of the personalized medicine in bladder cancer	15
Pharmacogenomics education in China and the United States: advancing personalized medicine	14
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing	12
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis	10
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease	9
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls	9
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer	8
Precision acute medical care through “-omic” analyses: a scoping review	8
Personalized approach in arrhythmology by genetic-based data: a case report	8
Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis	7
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study	6
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	6
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis	6
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models	6
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?	6
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation	6
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?	6
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children	5
Role of precision nutrition in improving military performance	5
Development of Competency-based Online Genomic Medicine Training (COGENT)	5

Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar	5
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups	5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	5
Welcome to the 19th Volume of Personalized Medicine	5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam	5
Looking Back Over 2023 and Welcome to the 21 ^st Issue of Personalized Medicine	5
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes	4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation	4
Genomics and the early diagnosis of lung cancer	4
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China	4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device	4
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	4
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head	4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System	4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population	4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead	4
A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality	3
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines	3
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	3
The United States 2020 Census Data: Implications for Precision Medicine and the Research Landscape	3
Development of a computer-based tool to obtain a family health history in Vietnam	3
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety	3
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice	3
Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan	3
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients	3
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients	3
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment	3
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young	3
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations	3
Association of miR-21 rs1292037 polymorphism with congenital heart disease susceptibility in Chinese children	3
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation	3
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus	3
Global harmonization in advanced therapeutics: balancing innovation, safety, and access	3
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis	3
Impact of MIR137HG rs7554283 on susceptibility to high-altitude pulmonary edema in the Chinese population	2
Preliminary Radiogenomic Study of Hepatitis B Virus-Related Hepatocellular Carcinoma: Associations between MRI Features and Mutations	2
Vancomycin individual dosing regimens via Bayesian simulation: a 5-year retrospective study on preterm and term neonates	2
CYP2D6 Genotyping and the Clinical Impact on Outcomes in Breast Cancer Tamoxifen-Treated Patients	2
Helping patients understand multi-cancer early detection tests: a scoping review	2
Corrigendum	2
Sars-Cov-2 Variant Identification Using a Genome Tiling Array and Genotyping Probes	2
Biomarker Testing in Patients Diagnosed With Advanced/Metastatic Medullary Thyroid Cancer in the USA	2
Pharmacogenomic analysis and clinical annotation of 635 patients	2
Anna Karenina Principle in Personalized Treatment of Bladder Cancer According to Oncogram: Which Drug for which Patient?	2
Challenges and Opportunities in Building a Health Economic Framework for Personalized Medicine in Oncology	2
How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability	2
Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer	2
Pharmacogenetic Testing in Pediatric Neurology: a Pragmatic Study Evaluating Clinician and Patient Perceptions	2
Association of platelet ADP receptor variant rs1371097 with inadequate platelet response to aspirin in Indian patients	1
HER2 in Gastric Adenocarcinoma: Where Do we Stand Today?	1

Maternal and Placental ANRIL Polymorphisms and Preeclampsia Susceptibility	1
A Visfatin Gene Promoter Polymorphism (Rs1319501) is Associated With Susceptibility to Nonalcoholic Fatty Liver Disease	1
Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report	1
Content Highlights of the Year: a Look Over 2022 at Personalized Medicine	1
A Sociogenomic Paradigm to Replace the Racial Paradigm	1
State-of-the-art knowledge on the regulation of advanced therapy medicinal products	1
Head-to-head comparison of tyrosine kinase inhibitors in renal cell carcinoma using patient-derived cell culture	1
LncRNA Polymorphisms and Lung Cancer Risk	1
Personalized Medicine in Nepal: Current Scenario and Challenges	1
Risk of Polymyxin B-Induced acute Kidney Injury with a Non Adjusted Dose Versus Adjusted Dose Based on Renal Function	1
Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk	1
Introduction of a single-nucleotide variant, rs16851030, into the ADORA1 gene increased cellular susceptibility to hypoxia	1
Five genes identified as prognostic markers for colorectal cancer through the integration of genome-wide association study and expression quantitative trait loci data	1
Aminoglycosides’ Dosage in Hematological Malignancies and Febrile Neutropenia: Extended Interval or Conventional Dosage?	1
Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin	1
The Roots of (in)Equity in Precision Medicine: Gaps in the Discourse	1
Association between PRNCR1 , PAX8AS1 , MEG3 , and PTENP1 gene polymorphisms	1
Optimizing breast cancer therapy: chemoressitance and machine learning for precision prediction	1
Navigating ethical problems of commercialization: towards inclusive organoid research	1
Development and evaluation of an exome sequencing training course for medical interpreters	1
Awareness, and interest in personalized medicine: a cross-sectional survey study of health professionals	1
Pathology-Supported Genetic Testing Presents Opportunities for Improved Disability Outcomes in Multiple Sclerosis	1
Prioritizing Pharmacogenomics Implementation Initiatives: A Survey of Healthcare Professionals	1
Successful Management of Delayed-Onset Adenosine Deaminase Deficiency with Novel Mutation	1
Evaluating the Quality of the Economic Evidence in Colorectal Cancer Genomics Studies	1
Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment	1
The effect of genetic polymorphisms of AKT1 on PE susceptibility: a case-control study and insilico analysis	1
A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report	1